Publication date: May 23, 2025
Lead: The AI Act is the legal core for regulating the rules of trade and use of AI technologies. This key document, which can be classified in the substantive law segment, should be read primarily as a list of “prohibitions” for full economic freedom for a noble purpose: namely, to maintain the right balance between market protection and Europe’s competitiveness vis-à-vis other global markets.
Publication date: May 20, 2025
INTRODUCTION
The conformity assessment process is a key element in ensuring the safety, quality and compliance of products with applicable standards and legal regulations – both on the domestic and international markets. Its effectiveness is based on the cooperation of many entities, each of which plays a specific role and bears the assigned responsibility. The participants of this process include manufacturers, their authorized representatives, importers, as well as specialized units – certification, control and research laboratories (Article 4 of the Act of 30 August 2002 on the conformity assessment system (Journal of Laws of 2023, item 215).
Publication date: May 09, 2025
In recent years, the dynamic development of artificial intelligence (AI) technology has become noticeable, which has significantly influenced various sectors of the digital economy. Currently, AI systems are widely used, among others, in the HR area (automation of recruitment processes), in e-commerce (analysis of consumer preferences), as well as in public administration (management of social benefits). This technological progress is characterized by enormous potential, but at the same time it raises serious legal and ethical challenges, especially in the area of privacy protection.
Publication date: May 14, 2025
New technologies requires a new approach to trading, where the speed of placing orders and the analysis of emerging trading options, while ensuring risk protection, becomes crucial for the success of trading activities. For this reason, we can currently observe the phenomenon of so-called algorithmic trading on the global market and on regional markets.
Publication date: April 29, 2025
The protection of personal data in clinical trials is one of the most important elements of ensuring the safety and privacy of participants in these trials. Due to the fact that clinical trials involve the processing of particularly sensitive health data, their conduct requires compliance with strict rules and the use of appropriate technical and organizational measures. Anonymization and pseudonymization is a key method for securing such data, and its proper application is important from both a legal and practical perspective.
